281 related articles for article (PubMed ID: 32868101)
1. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.
Liu L; Daftary MN; Alzahrani MS; Ohanele C; Maneno MK
J Natl Med Assoc; 2021 Apr; 113(2):147-157. PubMed ID: 32868101
[TBL] [Abstract][Full Text] [Related]
2. Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.
Sims OT; Guo Y; Shoreibah MG; Venkata K; Fitzmorris P; Kommineni V; Romano J; Massoud OI
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1219-1222. PubMed ID: 28857899
[TBL] [Abstract][Full Text] [Related]
3. High Hepatitis C Infection Rate Among Baby Boomers in an Urban Primary Care Clinic: Results from the HepTLC Initiative.
Geboy AG; Mahajan S; Daly AP; Sewell CF; Fleming IC; Cha HA; Perez IE; Cole CA; Ayodele AA; Fishbein DA
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):49-56. PubMed ID: 27168662
[TBL] [Abstract][Full Text] [Related]
4. Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.
Javanbakht M; Archer R; Klausner J
PLoS One; 2020; 15(11):e0241615. PubMed ID: 33147293
[TBL] [Abstract][Full Text] [Related]
5. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.
Clements KM; Clark RE; Lavitas P; Kunte P; Graham CS; O'Connell E; Lenz K; Jeffrey P
J Manag Care Spec Pharm; 2016 Jun; 22(6):714-722b. PubMed ID: 27231798
[TBL] [Abstract][Full Text] [Related]
6. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
7. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
9. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
Beck KR; Kim NJ; Khalili M
Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
[TBL] [Abstract][Full Text] [Related]
10. Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont.
Hale AJ; Mathur S; Dejace J; Lidofsky SD
Public Health Rep; 2023; 138(2):265-272. PubMed ID: 35264027
[TBL] [Abstract][Full Text] [Related]
11. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
[TBL] [Abstract][Full Text] [Related]
12. A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.
Scott J; Fagalde M; Baer A; Glick S; Barash E; Armstrong H; Kowdley KV; Golden MR; Millman AJ; Nelson NP; Canary L; Messerschmidt M; Patel P; Ninburg M; Duchin J
Hepatol Commun; 2021 Mar; 5(3):387-399. PubMed ID: 33681674
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C in Black Individuals in the US: A Review.
Falade-Nwulia O; Kelly SM; Amanor-Boadu S; Nnodum BN; Lim JK; Sulkowski M
JAMA; 2023 Dec; 330(22):2200-2208. PubMed ID: 37943553
[TBL] [Abstract][Full Text] [Related]
14. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
[TBL] [Abstract][Full Text] [Related]
15. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
[TBL] [Abstract][Full Text] [Related]
16. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490
[TBL] [Abstract][Full Text] [Related]
17. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
[TBL] [Abstract][Full Text] [Related]
18. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN
Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152
[TBL] [Abstract][Full Text] [Related]
19. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
Lin M; Kramer J; White D; Cao Y; Tavakoli-Tabasi S; Madu S; Smith D; Asch SM; El-Serag HB; Kanwal F
Aliment Pharmacol Ther; 2017 Nov; 46(10):992-1000. PubMed ID: 28949020
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
